Ryu Nakajima

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

Hisashi Saji, Morihito Okada, Masahiro Tsuboi et al. · The Lancet · 2022 · 1.5K citations

Surgical Oncology, Medicine, Cancer Management +10

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial

Kenji Suzuki, Hisashi Saji, Keiju Aokage et al. · Journal of Thoracic and Cardiovascular Surgery · 2019 · 488 citations · Full text

Interventional Pulmonology, Pulmonary Care, Outcomes Research +8

Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung

Yukio Hosomi, Tomoyuki Yokose, Yuko Hirose et al. · Lung Cancer · 2000 · 207 citations

Tumor Biology, Malignant Disease, Oncogenic Agent +10

Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

Keiju Aokage, Kenji Suzuki, Hisashi Saji et al. · The Lancet Respiratory Medicine · 2023 · 194 citations

Surgical Oncology, Phase 3, Medicine +10

Combination Chemotherapy with Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study

Seiji Niho, Hirotsugu Kenmotsu, Ikuo Sekine et al. · Journal of Thoracic Oncology · 2013 · 153 citations · Full text

Oncology, Combination Chemotherapy, Medicine +6